MDLN - Medline Inc. News

Barclays Maintains Overweight on Medline, Lowers Price Target to $43

Barclays analyst Glen Santangelo maintains Medline (NASDAQ:MDLN) with a Overweight and lowers the

MDLN Securities Alert: Lose Money on Your Medline Investment? BFA Law Notifies Investors of the Ongo

NEW YORK, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP a

MDLN ALERT: Kaplan Fox & Kilsheimer LLP is Investigating Medline Inc. (MDLN) for Potential Securitie

New York, New York--(Newsfile Corp. - October 8, 2026) - Kaplan Fox & Kilsheimer LLP is investigatin

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN

NEW YORK, Oct. 8, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors

defenseworld.net

Medline (NASDAQ:MDLN) Stock: Insider Private Ltd Gic Sells 2,570,999 Shares

Medline (NASDAQ: MDLN - Get Free Report) major shareholder Private Ltd Gic sold 2,570,999 shares of

MDLN Investor Reminder: BFA Law Reminds Medline Investors that Lost Money when Stock Dropped 13% of

NEW YORK, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Medline Inc. - MDLN

NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves

Kaplan Fox is Investigating Medline Inc. (MDLN) for Investors Who Suffered Losses

New York, New York--(Newsfile Corp. - October 6, 2026) - Kaplan Fox & Kilsheimer LLP is investigatin

businesswire.com

MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm's Securities Investigation F

NEW YORK--(BUSINESS WIRE)---- $MDLN #ClassActionLawsuit--The law firm of Kirby McInerney LLP reminds

Medline to report third quarter 2026 results on November 4, 2026

NORTHFIELD, Ill., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today an

gurufocus.com

MDLN Stock Notice: Medline Stock Plummeted 13% after Product Quality Issues Disclosed - Securities F

MDLN Stock Notice: Medline Stock Plummeted 13% after Product Quality Issues Disclosed - Securities F

BFA Law is investigating whether Medline Inc. committed securities fraud relating to statements abou

MDLN Investigation Notification: Medline is Under Investigation for Securities Fraud over Product Qu

NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP

Kaplan Fox Urges Investors of Medline Inc. (MDLN) with Losses to Contact the Firm

New York, New York--(Newsfile Corp. - October 2, 2026) - Kaplan Fox & Kilsheimer LLP is investigatin

$MDLN Shareholder Notice: A Securities Fraud Investigation is Ongoing on behalf of Medline Investors

NEW YORK, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP

Bragar Eagel & Squire, P.C. is Investigating Medline Inc. on Behalf of Medline Stockholders and Enco

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered L

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN

NEW YORK, Oct. 1, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors

Kaplan Fox Reminds Investors of Medline Inc. (MDLN) of an Ongoing Securities Investigation

New York, New York--(Newsfile Corp. - September 30, 2026) - Kaplan Fox & Kilsheimer LLP is investiga

$MDLN Investigation Notification: Suffer Losses on Your Medline Investment? BFA Law Reminds Investor

NEW YORK, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN

NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inve

Medline Legal Alert: Medline (MDLN) Investors who Lost Money are Notified of the Ongoing Securities

BFA Law is investigating whether Medline Inc. committed securities fraud relating to statements abou

UBS Maintains Buy on Medline, Lowers Price Target to $43

UBS analyst Kevin Caliendo maintains Medline (NASDAQ:MDLN) with a Buy and lowers the price target

Medline Convenience Kits Impacted By Contamination In Recalled Becton Dickinson Products

FDA alerts providers as Medline corrects convenience kits with recalled BD applicators due to steril

JP Morgan Maintains Overweight on Medline, Lowers Price Target to $46

JP Morgan analyst Lisa Gill maintains Medline (NASDAQ:MDLN) with a Overweight and lowers the pric

Wells Fargo Maintains Equal-Weight on Medline, Lowers Price Target to $34

Wells Fargo analyst Stephen Baxter maintains Medline (NASDAQ:MDLN) with a Equal-Weight and lowers

TD Cowen Maintains Buy on Medline, Lowers Price Target to $45

TD Cowen analyst Charles Rhyee maintains Medline (NASDAQ:MDLN) with a Buy and lowers the price ta

RBC Capital Maintains Outperform on Medline, Lowers Price Target to $46

RBC Capital analyst Ryan Halsted maintains Medline (NASDAQ:MDLN) with a Outperform and lowers the

Truist Securities Maintains Buy on Medline, Lowers Price Target to $47

Truist Securities analyst Jailendra Singh maintains Medline (NASDAQ:MDLN) with a Buy and lowers t

Evercore ISI Group Maintains Outperform on Medline, Lowers Price Target to $39

Evercore ISI Group analyst Elizabeth Anderson maintains Medline (NASDAQ:MDLN) with a Outperform a

Gold Jumps 4%, Dow Jones Smashes Record Highs: Stock Market Today

Gold posts its biggest one-day gain since February and the Dow sets a record as Iran deal hopes cool

Medline Q2 Adj. EPS $0.50 Beats $0.32 Estimate, Sales $7.685B Beat $7.512B Estimate

Medline (NASDAQ:MDLN) reported quarterly earnings of $0.50 per share which beat the analyst consensu

Medline Strikes New Prime Vendor Agreement To Offer Access To Its Portfolio Of Medical-Surgical Prod

Medline (NASDAQ:MDLN) today announced that it signed a new Prime Vendor agreement with Allina Health

Jim Cramer: 'Go For' AST SpaceMobile, Power Plant Maker 'Too Speculative'

Jim Cramer says Medline is "probably" the best IPO of 2026 and expects AST SpaceMobile to be

Medline Distribution Center Fire Creates Near-Term Headwind: Analyst

Medline (MDLN) faces near-term headwinds after a major CA warehouse fire. William Blair analysts bre

Baird Maintains Outperform on Medline, Lowers Price Target to $45

Baird analyst Eric Coldwell maintains Medline (NASDAQ:MDLN) with a Outperform and lowers the pric

FDA Sends Warning Letter To Medline Over CGMP Violations For Finished Pharmaceuticals On May 28

https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/m

Barclays Maintains Overweight on Medline, Lowers Price Target to $45

Barclays analyst Glen Santangelo maintains Medline (NASDAQ:MDLN) with a Overweight and lowers the

Medline Announces That Medline Canada Has Signed Its First Prime Vendor Agreement In The Country And

Medline (NASDAQ:MDLN) announced that Medline Canada has signed its first Prime Vendor agreement in t

Medline Signs Prime Vendor Agreement With Rural Medical Services; Agreement Enables Access To Medlin

Medline (NASDAQ:MDLN) today announced that it signed a new Prime Vendor agreement with Rural Medical

Medline Announces Secondary Public Offering Of 60M Shares

Medline Inc. (NASDAQ:MDLN) ("Medline") announced today that certain selling stockholders aff

BNP Paribas Maintains Neutral on Medline, Lowers Price Target to $40

BNP Paribas analyst Navann Ty maintains Medline (NASDAQ:MDLN) with a Neutral and lowers the price

Tigress Financial Maintains Buy on Medline, Raises Price Target to $62

Tigress Financial analyst Ivan Feinseth maintains Medline (NASDAQ:MDLN) with a Buy and raises the

Citigroup Maintains Buy on Medline, Lowers Price Target to $55

Citigroup analyst Patrick Donnelly maintains Medline (NASDAQ:MDLN) with a Buy and lowers the pric

Bernstein Maintains Outperform on Medline, Lowers Price Target to $54

Bernstein analyst Lee Hambright maintains Medline (NASDAQ:MDLN) with a Outperform and lowers the

Earnings Scheduled For May 6, 2026

FDA Announces Medline Recalls All Of Its Stock Keeping Units In Medline Branded Neuro Sponge Categor

https://www.fda.gov/medical-devices/letters-health-care-providers/disruptions-availability-neurosurg

Medline Q1 2026 Earnings Call: Complete Transcript

Medline Q1 EPS $0.33 Beats $0.23 Estimate, Sales $7.400B Beat $7.163B Estimate

Medline (NASDAQ:MDLN) reported quarterly earnings of $0.33 per share which beat the analyst consensu

FDA Recalls Several Medline Products

https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=219163